BU.TO - Burcon NutraScience Corporation
| Previous Close | 1.4300 |
| Open | 1.4200 |
| Bid | 1.3800 x 0 |
| Ask | 1.4000 x 0 |
| Day's Range | 1.3800 - 1.4400 |
| 52 Week Range | 0.1800 - 1.9800 |
| Volume | 205,083 |
| Avg. Volume | 300,877 |
| Market Cap | 122.593M |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0790 |
| Earnings Date | Feb. 13, 2020 - Feb. 18, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.85 |
- Newsfile
Merit Functional Foods Receives Co-Investment from Protein Industries Canada
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2020) - Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to share that its joint venture company, Merit Functional Foods Corporation ("Merit Foods") announced today that it has received a significant co-investment from Protein Industries Canada, which will help facilitate the rapid growth of Merit Foods.Merit Foods was established in May 2019 as a joint venture with Burcon ...
- Newsfile
Burcon Closes Non-Brokered Private Placement of Convertible Debentures for $9.5 Million
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins, is pleased to announce that it has closed its previously announced non-brokered private placement (see news releases of the Company dated November 25, 2019 and November 28, 2019) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $9.5 million (the "Offering"). Insiders ...
- Newsfile
CORRECTION: Burcon Increases Previously Announced Non-Brokered Private Placement of Convertible Debentures to $9.5 Million
This document corrects and updates the headline where it should have read, "Burcon Increases Previously Announced Non-Brokered Private Placement of Convertible Debentures to $9.5 Million" instead of "$9 Million". No other changes were required in the body of the release. Vancouver, British Columbia--(Newsfile Corp. - November 28, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins, is pleased to announce that, based ...
- Newsfile
Burcon Increases Previously Announced Non-Brokered Private Placement of Convertible Debentures to $9.5 Million
Vancouver, British Columbia--(Newsfile Corp. - November 28, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins, is pleased to announce that, based on orders received, it has increased its previously announced non-brokered private placement (see news release of the Company dated November 25, 2019) of convertible debentures (the "Convertible Debentures") from an aggregate principal amount of $4 million to $9.5 million ...
- Newsfile
Burcon Announces Non-Brokered Private Placement of Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins, is pleased to announce a non-brokered private placement of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of up to $4 million (the "Offering"). Insiders of the Company have agreed to subscribe for Convertible Debentures totaling $2 million in principal amount. The ...
- Newsfile
Peazazz and Peazac Pea Proteins FDA GRAS Notified
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2019) - Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to announce today that the US Food and Drug Administration ("FDA") has issued a GRAS (Generally Recognized As Safe) no-objection letter for Peazazz® and Peazac® pea proteins. The "Letter of No Objection" is issued by the US FDA confirming that they do not question the basis for ...
- Newsfile
Burcon Announces Results of Shareholder Meeting
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2019) - Burcon NutraScience Corporation (TSX: BU) a global technology leader in the development of plant-based proteins, is pleased to announce the results from its 2019 annual meeting of shareholders (the "Meeting") held on September 17, 2019. All of the seven nominees set out in Burcon's management proxy circular dated July 30, 2019 proposed by management for election to the board of directors at the Meeting ...
- Newsfile
Burcon Updates on Development Activities
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2019) - Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to provide an update of its recent development activities. Burcon and its partners have now funded their full share of the capital contributions to Merit Functional Foods Corporation ("Merit Foods" or "Merit") as originally planned. As previously announced, following their initial contributions in June 2019, Burcon ...
- Newsfile
Burcon Receives Notice of Allowance from the United States Patent Office for Peazazz Pea Protein Patent
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2019) - Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, announced today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering certain valuable attributes of Burcon's Peazazz® pea protein. A notice of allowance from the United States Patent and Trademark Office is a written notification that a ...
- Newsfile
Burcon Announces Appointment of Calvin Chi Leung Ng to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2019) - Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, is pleased to announce the appointment of Mr. Calvin Chi Leung Ng as a director of its board. Mr. Ng is a director of Large Scale Investments Limited ("Large Scale") and Great Intelligence Limited ("Great Intelligence"), two companies that together own in the aggregate, approximately 26% of the common ...
- Baystreet
Stocks in play: Burcon NutraScience Corporation
Provided an update of its recent development activities. Burcon has now funded its share of the initial ...
- Newsfile
Burcon Announces Details of Over-Subscribed Rights Offering
Vancouver, British Columbia--(Newsfile Corp. - July 4, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon"), a leader in developing functionally and nutritionally valuable plant proteins, is pleased to announce that, further to its press release dated June 26, 2019 with respect to the completion of Burcon's rights offering (the "Rights Offering"), the Rights Offering was over-subscribed and, as such, Burcon has issued 44,083,203 Common shares of Burcon ("Common Shares") at a ...
- Newsfile
Burcon Announces Fiscal 2019 Results and Reviews Operations
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2019) - Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, reported results for the year ended March 31, 2019. "Fiscal 2019 proved to be a turning point in consumer appetites for plant-based foods and a watershed moment in Burcon's history," said Johann F. Tergesen, Burcon's president and chief executive officer. He added: "Looking back on the year, ...
- Newsfile
Burcon Announces Completion of Over-Subscribed Rights Offering
Vancouver, British Columbia--(Newsfile Corp. - June 26, 2019) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a leader in developing functionally and nutritionally valuable plant proteins, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on June 25, 2019. The Rights Offering was over-subscribed and will result in the issuance of 44,083,203 Common shares of Burcon ("Common Shares") at a price of $0.35 ...
- Newsfile
Burcon Introduces JV Partner
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2019) - Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, is pleased to introduce the investor group and joint venture partner for its new $65 million pea-protein and canola-protein production facility to be built in Western Canada. The investor group is made up of Shaun Crew, Barry Tomiski and Ryan Bracken, three exceptionally talented veterans of the agri-foods ...
- ACCESSWIRE
Burcon to Present at 9th Annual LD Micro Invitational Conference, June 4-5, 2019
VANCOUVER, BC and BEL-AIR, CA / ACCESSWIRE / May 30, 2019 / Burcon NutraScience Corporation (BU.TO), a global leader in developing functionally and nutritionally valuable plant-proteins, has been invited to present at the 9th Annual LD Micro Invitational Conference being held on June 4-5, 2019 at the Luxe Sunset Hotel in Bel-Air, California. Burcon CEO, Johann Tergesen, is scheduled to present on June 4, 2019 at 9:00 a.m. PT with one-on-one meetings throughout the day. The plant will produce unique, highly purified pea and canola protein ingredients based on Burcon's patented technologies.
- Baystreet
Algonquin, Morneau at 52-week Highs
Algonquin Power & Utilities Corp. (T.AQN) hit a new 52-week high of $15.90 Monday. No news announcements ...
